The symptoms of immune hemolytic anemia include pale or yellowish skin color, tiredness or fatigue, fast heartbeat or heart rate, shortness of breath, enlarged spleen, and dark urine. The disease is diagnosed by performing several tests. The following indicate that the patient is suffering from the disease: Coombs’ test turning out positive direct or indirect; increased bilirubin levels; increased LDH level (LDH are enzymes that increase when the body is experiencing tissue damage); presence of hemoglobin in the urine; decreased serum haptoglobin level; increased reticulocyte count; and decreased hemoglobin and RBC count.
===Name of drug=== *Will be capitalized if it is a trade name (brand name) or uncapitalized if it is a generic name. *Two trade names that are nearly identical (eg Adalat PA and Adalat XL) need not have separate entries unless there is a particular reason for doing so. *Names will be listed alphabetically and broken into an appropriate number of pages (with 200-500??? items per page) Peg-Intron is the correct spelling that you have listed as Pegetron for pegylated interferaon alfa2b made by schering plough and marketed in the US for HCV
Course and treatment of autosomal dominant polycystic kidney disease
Diagnosis of and screening for autosomal dominant polycystic kidney disease
Extrarenal manifestations of autosomal dominant polycystic kidney disease
Genetics of autosomal dominant polycystic kidney disease and mechanisms of cyst growth
Hypertension in autosomal dominant polycystic kidney disease
Prenatal sonographic diagnosis of cystic renal disease
Renal manifestations of autosomal dominant polycystic kidney disease
Screening for intracranial aneurysm
Urinary tract infection in autosomal dominant polycystic kidney disease
The following organizations also provide reliable health information.